MEK5 Antibody [Allophycocyanin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-97478APC
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human, Mouse, Rat, Canine, Primate, Rabbit, Sheep, Xenopus
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot
Label
Allophycocyanin (Excitation = 620-650 nm, Emission = 660-670 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Synthetic peptide corresponding to a portion of human MEK5.
Reactivity Notes
Recognizes Human, Mouse, Rat, Canine, Primate, Rabbit, Sheep and Xenopus MEK5.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for MEK5 Antibody [Allophycocyanin]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: MEK5
Long Name
Mitogen-activated Protein Kinase Kinase 5
Alternate Names
MAP2K5, MAPKK5, MKK5, PRKMK5
Gene Symbol
MAP2K5
Additional MEK5 Products
Product Documents for MEK5 Antibody [Allophycocyanin]
Product Specific Notices for MEK5 Antibody [Allophycocyanin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...